Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Infection and Immunity|December 24, 2002
Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cellsDuane C Hassane, Robert B Lee, Carol L PickettCancer Letters|June 21, 2012
Acute myelogenous leukemia stem cells: from Bench to BedsideJ Felipe Rico, Duane C Hassane, Monica L GuzmanInfection and Immunity|August 23, 2003
Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cellsRobert B Lee, Duane C Hassane, Daniel L Cottle, et al.Experimental Hematology|May 11, 2013
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activitySiddhartha Sen, Duane C Hassane, Cheryl Corbett, et al.Cold Spring Harbor Perspectives in Medicine|October 17, 2019
Clonal Hematopoiesis and Premalignant DiseasesJustin Kaner, Pinkal Desai, Nuria Mencia-Trinchant, et al.Leukemia & Lymphoma|July 19, 2017
CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabineJohn N Allan, Gail J Roboz, Gulce Askin, et al.Blood|February 29, 2008
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression dataDuane C Hassane, Monica L Guzman, Cheryl Corbett, et al.Nature|November 3, 2017
Single-cell RNA sequencing reveals a signature of sexual commitment in malaria parasitesAsaf Poran, Christopher Nötzel, Omar Aly, et al.Blood|October 5, 2010
Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathwaysDuane C Hassane, Siddhartha Sen, Mohammad Minhajuddin, et al.Cancer|May 19, 2017
The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosisRichard T Silver, Ariella C Barel, Elena Lascu, et al.Pageof 4